SEC Form 4 · accession 0001209191-17-034712
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian R Ahrens
Officer — Vice President, Sales
Period of report
May 21, 2017
Accepted (ET)
May 23, 2017 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 21, 2017 | A | 10,623 | A | — | — | Common Stock | 10,623 | 10,623 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock.
- F2The restricted stock units vested with respect to 100% of the total shares subject to the grant on the date of the grant. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.